Structural mechanisms of fibroblast growth factor receptor signalling at the membrane interface
Structural mechanisms of fibroblast growth factor receptor signalling at the membrane interface
批准号:
2271320
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2019
资助国家:
英国
项目状态:
未结题
起止时间:
2019 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fibroblast growth factor receptors (FGFRs) are receptor tyrosine kinases that play key roles in embryo development, tissue remodelling, wound healing, and cancer. An enduring enigma of FGFR signalling is the question of how the output (activation of a specific signalling module, e.g. Raf-Mek-Erk) is selected based on the nature and level of the input signal (binding of a particular FGF variant). In this project, you will combine structural biology and biophysical (native MS & structural proteomics) approaches together with mutagenesis, cell biology and imaging to elucidate key mechanistic features of the interaction between the kinase domain, juxtamembrane region and membrane lipids, and determine how these interactions influence downstream signalling through the constitutively-bound FGFR adaptor protein, FRS2.Specifically, you will:1. Characterise the interaction between membrane lipids and the JM-KD of FGFR3 using NMR in a membrane-mimetic system (e.g. nanodiscs)2. Use native mass spectrometry (MS) & structural proteomics methods pioneered in Leeds, including ion-mobility (IM-MS), hydrogen-deuterium exchange (HDX-MS) and fast photochemical oxidation of proteins (FPOP), to provide orthogonal structural mapping of lipid-protein interactions as well as characterisation of the lipid composition around natively-expressed FGFRs.3. Elucidate how FGFR3 JM-KD and the membrane-anchored adapter protein FRS2 interact using NMR, MS and cell-based imaging approaches.The student will benefit from the Astbury Centre's world-leading structural biology infrastructure, with >£20M of recent investment, with specialist equipment including 950 MHz NMR, top-end Orbitrap protein mass spectrometry and Titan Krios cryo-EM.Leeds and AstraZeneca have synergistic expertise in FGFR cell biology and structural biology and together can provide cutting-edge infrastructure to the project and provide a unique competitive advantage to the student, with a highly distinctive research experience that can be effectively levered for future career opportunities, whether academic or industrial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: